Yingke backs Laviana and 17 more deal updates from Greater China

Shanghai-headquartered private equity firm Yingke PE has led nearly 500 million yuan ($78 million) Series C round funding in Laviana Pharma Co., Ltd, a contract development manufacture organisation (CDMO) driven pharmaceutical firm. 

The new round saw the participation of return investor HY Capital and new backers such as state-backed HRVC Capital and Space Holding Group, the investee announced on Wednesday. 

The company will deploy the proceeds towards the construction of a manufacturing facility, research laboratory, and new drugs R&D. 

Established in 2005, Laviana has set up three fully-owned subsidiaries in China and one overseas unit in the US.

Laviana had earlier completed three other rounds of financing from China Merchants Wealth Management, LYFE Capital, ABC Capital, Lotus Lake Capital, among others.

CHINA DEAL MONITOR

DealStreetAsia has also put together a table listing out all prominent venture capital transactions in the Greater China region on October 12 – 13, 2021. 

Expand Table

StartupHeadquarterInvestment Size (USD)Investment StageLead Investor(s)Other Investor(s)Verticals
NeuSARShanghai101 millionDebutCMG-SDIC CapitalVirtue CapitalAutonomous Driving
AgotoZ Technology (Beijing) Beijing78 millionC-Legend Capital Cloud Computing
Laviana PharmaJiangyan78 millionCYingke PEShiyue Capital, HRVC Capital, Space Holding Group, Xingzheng Innovation, Yinglian Fund, Yueshi Investment, Space Holding Group, Pingtan Yihe, HY CapitalN/A
Huakong TsingJiao Information Science (Beijing) Beijing78 millionB-Lenovo Capital, China Renaissance, Beijing Zhongguancun Science City Construction Holding, Everest VC, Cowin CapitalBig Data
Sciwind BiosciencesHangzhou69 millionCIDG Capital -Biotech
WhaleHangzhou50 millionBTemasek HoldingsNIO Capital, Linear Capital, Alpha StartupsBig Data
Sky Limit EntertainmentBeijing* 15 million BXiaomi Zhantou, CCB International Lenovo Capital, Weed VenturesInfrastructure
RedpineGuangzhou* 15 million B-Eight Road Venture, Shanghai Guofang Capital, Xiangtang Capital, Oriza Seed, Cowin CapitalHealthTech
YeloworldShanghai15 millionB-Wanhua Chemical Group, GL VenturesCleanTech
Beijing Kaideni Medical TechnologyBeijing15 millionA+MSA Capital Yidu CloudHealthTech
Small Design Hangzhou11 millionASource Code Capital Sequioa Capital China Seed Fund, GL Ventures, Vision Plus Capital AI and Machine Learning
Hours Suzhou10 millionPre-A5Y Capital, Matrix Partners China Linear Capital AI and Machine Learning
haoyishu.orgShanghai7.8 millionA-Long Hill Capital HealthTech
iROSShanghai* 1.5 millionPre-A-Redpoint Ventures China Saas
RuiweishiNanjing* 1.5 millionAngelLinear CapitalOfound Angel AR & VR
ZYNALOGSuzhou* 1.5 millionDebut--N/A
Yishao FoodShenzhen* 1.5 millionPre-A-Buer Capital N/A
TikinMediaBeijing-B4, B5B5: Bojiang Capital B4: Greenland Jinchuang; B5: Mirae Asset, Lan FundDigital Media

∗ indicates that the company did not provide the specific size of the deal but only a range. So, we adopt the smallest number in the range, which is “10 million yuan ($1.5 million)” in the given example. 

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.